Regulation of Proteoglycan Synthesis by Leukotriene D4 and Epidermal Growth Factor in Bronchial Smooth Muscle Cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 1, 2004, Pages 101-108

  Potter Perigo, Susan ^b   Baker, Coralie ^b   Tsoi, Christina ^b   Braun, Kathleen R ^b   Isenhath, Scott ^b   Altman, Gaylene M ^b   Altman, Leonard C ^b   Wight, Thomas N ^a  

^a HOPE HEART INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; LEUKOTRIENE D4; PROTEOGLYCAN; VERSICAN;

ARTERY MUSCLE; ARTICLE; ASTHMA; ATHEROSCLEROSIS; BRONCHUS MUSCLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; REDUCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRONCHI; CELLS, CULTURED; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; HUMANS; LEUKOTRIENE D4; MUSCLE, SMOOTH; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BRONCHUS;

EID: 0347634279     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0050OC     Document Type: Article

References (58)

1. Redington, A. E., and P. H. Howarth. 1997. Airway wall remodeling in asthma. Thorax 52:310-312.
2. Chetta, A., A. Foresi, M. DelDonno, G. Bertorelli, A. Pesci, and D. Olivieri. 1997. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 111:852-857.
3. Roberts, C. R. 1995. Is asthma a fibrotic disease? Chest 107:111S-117s.
4. Roberts, C. R., T. N. Wight, and V. C. Hascall. 1997. Proteoglycans. In The Lung: Scientific Foundations, 2nd ed. R. G. Crystal and J. B. West, editors. Lippincott-Raven Publishers, Philadelphia, PA. 757-767.
5. Altraja, A., A. Laitinen, I. Virtanen, M. Kämpe, B. G. Simonsson, S. Karlsson, L. Häkansson, P. Venge, H. Sillastu, and L. A. Laininen. 1996. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am. J. Respir. Cell Mol. Biol. 15:482-488.
6. Laitinen, A., A. Altraja, M. Kampe, M. Linden, I. Virtanen, and L. A. Laitinen. 1997. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 156:951-958.
7. Pare, P. D., J. R. Bai, and C. R. Roberts. 1996. The structural and functional consequences of chronic allergic inflammation of the airways. Ciba Found. Symp. 206:71-86.
8. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Superepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
9. Brewster, C. E. P., P. H. Howarth, J. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3:507-511.
10. Holgate, S. T., D. E. Davies, P. M. Lackie, S. J. Wilson, S. M. Puddicombe, and J. L. Lordan. 2000. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J. Allergy Clin. Immunol. 105:193-204.
11. Page, C. 2000. The role of proteoglycans in the regulation of airways inflammation and airways remodeling. J. Allergy Clin. Immunol. 105:S518-S521.
12. Huang, J., R. Olivenstein, R. Taha, Q. Hamid, and M. Ludwig. 1999. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am. J. Respir. Crit. Care Med. 160:725-729.
13. Bensadoun, E. S., A. K. Burke, J. C. Hogg, and C. R. Roberts. 1996. Proteoglycan deposition in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154: 1819-1828.
14. Karlinsky, J. B. 1982. Glycosaminoglycans in emphysematous and fibrotic hamster lungs. Am. Rev. Respir. Dis. 125:85-88.
15. Cantor, J. O., M. Cerrata, S. H. Mott, I. Mandl, and G. M. Turino. 1983. Glycosaminoglycan synthesis in bleomycin-induced pulmonary fibrosis: biochemistry and autoradiography. Proc. Soc. Exp. Biol. Med. 174:172-181.
16. Roberts, C. 2002. Versican in the cell biology of pulmonary fibrosis. In Proteoglycans in Lung Disease, Lung Biology in Health and Disease. H. A. Garg, P. J. Roughly, and C. N. Hales, editors. Marcel Dekker, NY. 168.
17. Shute, J. K., J. Criss, P. Hockey, and P. H. Howarth. 1998. Increased proteoglycans in sputum in asthma and cystic fibrosis (CF) and increased GAG levels in CF [C48: Poster: L63; Abstract page: A607]. ALA/ATS International Conference, April 24-29. 1998.
18. Tremblay, G. M., M. J. Lafreniere-Allard, G. Westergren-Thorsson, A. Malmstrom, J. Chakir, J. Dube, and L. P. Boulet. In vitro production of proteoglycans by asthmatic bronchial fibroblasts correlates with airway hyperresponsiveness [A91; Poster: 513; Abstract page: A247]. ALA/ATS International Conference, April 24-29, 1998.
19. Wight, T. N., M. G. Kinsella, and E. Qwarnström. 1993. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4:793-801.
20. Vignola, A. M., G. Chiappara, P. Chanez, A. M. Merendino, E. Pace, M. Spatafora, J. Bousquet, and G. Bonsignore. 1997. Growth factors in asthma. Monaldi Arch. Chest Dis. 52:159-169.
21. Strandjord, T. P., J. G. Clark, and D. K. Madtes. 1994. Expression of TGF-alpha, EGF, and EGF receptor in fetal rat lung. Am. J. Physiol. 267:L384-L389.
22. Amishima, M., M. Munakata, Y. Nasuhara, A. Sato, T. Takahashi, Y. Homma, and Y. Kawakami. 1998. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am. J. Respir. Crit. Care Med. 157:1907-1912.
23. Wenzel, S. E. 1997. Arachadonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17:3S-12S.
24. Leff, A. R. 2001. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. Annu. Rev. Med. 52:1-14.
25. Porreca, E., C. Di Febbo, M. Reale, R. Barbacane, A. Mezzetti, F. Cuccurullo, and P. Conti. 1995. Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1. Atherosclerosis 113:11-18.
26. Palmberg, L., H. E. Claesson, and J. Thyberg. 1989. Effects of leukotrienes on phenotypic properties and growth of arterial smooth muscle cells in primary culture. J. Cell Sci. 93:391-399.
27. Palmberg, L., J. A. Lindgren, J. Thyberg, and H. E. Claesson. 1991. On the mechanism of induction of DNA synthesis in cultured arterial smooth muscle cells by leukotrienes: possible role of prostaglandin endoperoxide synthase products and platelet-derived growth factor. J. Cell Sci. 98: 141-149.
28. Panettieri, R. A., Jr., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hay. 1998. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 19:453-461.
29. Johnson, P. R. A., J. L. Black, S. Carlin, Q. Ge, and P. A. Underwood. 2000. The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture. The effect of beclomethasone. Am. J. Respir. Crit. Care Med. 162:2145-2151.
30. Wight, T. N., S. Potter-Perigo, and T. Aulinskas. 1989. Proteoglycans and Vascular Cell Proliferation. Am. Rev. Respir. Dis. 140:1132-1135.
31. Schönherr, E., H. T. Järveläinen, L. J. Sandell, and T. N. Wight. 1991. Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266:17640-17647.
32. Lynch, K. R., G. P. O'Neil, Q. Liu, D. S. Im, N. Sawyer, K. M. Metters, N. Coulombe, M. Abramovitz, D. J. Figueroa, Z. Zeng, B. M. Connolly, C. Bai, C. P. Austin, A. Chateauneuf, R. Stocco, G. M. Greig, S. Kargman, S. B. Hooks, E. Hosfield, D. L. Williajms, Jr., A. W. Ford-Hutchinson, C. T. Caskey, and J. F. Evans. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399:789-793.
33. Desmouliere, A., and G. Gabbiani. 1996. The role of the myofibroblast in wound healing and fibrocontractive diseases. In The Molecular and Cellular Biology of Wound Repair. R. A. Clark, editor. Plenum Press, New York. 311-338.
34. Ross, R., J. Glomset, B. Kariya, and L. Harker, 1974. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA 71:1207-1210.
35. Schönherr, E., H. T. Järveläinen, M. G. Kinsella, L. J. Sandell, and T. N. Wight. 1993. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 13: 1026-1036.
36. Wasteson, A., K. Uthne, and B. Westermark. 1973. A novel assay for the biosynthesis of sulphated polysaccharide and its application to studies on the effects of somatomedin on cultured cells. Biochem. J. 136:1069-1074.
37. Saito, H., T. Yamagata, and S. Suzuki. 1968. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J. Biol. Chem. 243:1536-1542.
38. Zimmerman, D. R., and E. Ruoslahti. 1989. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8:2975-2981.
39. Fisher, L. W., J. D. Termine, and M. F. Young. 1989. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264:4571-4576.
40. Day, A. A., C. I. McQuillan, J. D. Termine, and M. R. Young. 1987. Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. Biochem. J. 248:801-805.
41. Dodge, G. F., I. Kovalszky, M. L. Chu, J. R. Hassell, O. W. McBride, H. F. Yi, and R. V. lozzo. 1991. Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome #1. 10:673-680.
42. Chu, M. L., J. C. Myers, M. P. Bernard, J. F. Ding, and F. Ramirez. 1982. Cloning and characterization of five overlapping cDNAs specific for the human pro α 1 (I) collagen chain. Nucleic Acids Res. 10:5925-5934.
43. Baley, P., I. Lutzelschwab, T. Scott-Burden, W. Kung, and U. Eppenberger. 1990. Modulation of extracellular-matrix synthesized by cultured stromal cells from normal human breast tissue by epidermal growth factor. J. Cell. Biochem. 43:111-125.
44. Rappolee, D. A., D. Mark, M. J. Banda, and Z. Werb. 1988. Wound macrophage express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 241:708-712.
45. West, D. C., A. Sattar, and S. Kumar. 1985. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal. Biochem. 147:289-295.
46. Olin, K. L., S. Potter-Perigo, P. H. Barrett, T. N. Wight, and A. Chait. 1999. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J. Biol. Chem. 274:34629-34636.
47. Chamley-Campbell, J. H., R. G. Campbell, and R. Ross. 1981. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell Biol. 89:379-383.
48. Nikkari, S. T., H. T. Järveläinen, T. N. Wight, M. Ferguson, and A. W. Clowes. 1994. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am. J. Pathol. 144:1348-1356.
49. Wight, T. N. 1996. The vascular extracellular matrix. In Atherosclerosis and Coronary Artery Disease. V. Fuster, R. Ross, and E. J. Topol, editors. Raven Press, New York. 421-440.
50. Wight, T. N., S. Lara, R. Riessen, R. Le Baron, and J. Isner. 1997. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. Am. J. Pathol. 151:963-973.
51. Theocharis, A. D., I. Tsolakis, A. Hjerpe, and N. K. Karamanos. 2001. Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V0, Atherosclerosis 154:367-376.
52. Heise, C. E., B. F. O'Dowd, D. J. Figueroa, N. Sawyer, T. Nguyen, D. S. Im, R. Stocco, J. N. Bellefeuille, M. Abramovitz, R. Cheng, D. L. Williams, Z. Zeng, Q. Liu, L. Ma, M. K. Clements, N. Coulombe, Y. Liu, C. P. Austin, S. R. George, G. P. O'Neill, K. M. Metters, K. R. Lynch, and J. F. Evans. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275:30531-30536.
53. Järveläinen, H. T., M. L. Iruela-Arispe, M. G. Kinsella, L. J. Sandell, E. H. Sage, and T. N. Wight. 1992. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp. Cell Res. 203: 395-401.
54. Pogany, G., D. J. Hernandez, and K. G. Vogel. 1994. The in vitro interaction of proteoglycans with type 1 collagen is modulated by phosphate. Arch. Biochem. Biophys. 31113:102-111.
55. Danen, E. H., and K. M. Yamada. 2001. Fibronectin, integrins, and growth control. J. Cell. Physiol. 189:1-13.
56. Qwarnström, E., H. Järveläinen, M. Kinsella, C. Ostberg, L. Sandell, R. Page, and T. Wight. 1993. Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem. J. 294:613-620.
57. Roberts, C. R., and A. K. Burke. 1998. Remodeling of the extracellular matrix in asthma: proteolgycans synthesis and degradation. Can. Respir. J. 5:48-50.
58. Evanko, S. P., J. C. Angello, and T. N. Wight. 1999. Formation of versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:213-225.